Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Guidelines for lowering lipids...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
Bibliographic Details
Main Authors:
Davidson, M
,
Wood, D
,
Paoletti, R
,
Hobbs, R
,
Shepherd, J
,
Brown, W
,
Hunninghake, D
,
McKenney, J
Format:
Journal article
Published:
2003
Holdings
Description
Similar Items
Staff View
Similar Items
Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion
by: Stein, E, et al.
Published: (2003)
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
by: Gounari, P, et al.
Published: (2010)
Lipid-lowering trials in diabetes
by: Armitage, J
Published: (1999)
Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
by: Margaritis, M, et al.
Published: (2012)
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2006)